N-(2-(3,4-Dimethoxyphenyl)ethyl)-2-nitriloethanamide, 98%, 98.0%, 1g

Patchouli Oil Artificial 25ml Glass Packaging

2-(4-Methyl-tetrahydro-2H-pyran-4-yl)acetic acid, 99%, 1g

2-((2-Acetamido-6-oxo-1H-purin-9(6H)-yl)methoxy)propane-1,3-diyl diacetate, 97.0%, 100g

Plan phase PLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

2-((3-(4-Cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methyl-N-(methylsulfonyl)propanamide 2,2,2-trifluoroacetate, 97%, 100mg

Methyl 4-bromo-3-chlorobenzoate, 99.0%, 1g

3,4-Difluoro-2-hydroxybenzoic acid, 99.0%, 1g

2,3,5,6-Tetrafluoro-1,4-benzenedimethanol>97.0%(GC)5g

5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, 95.0%, 100mg

3-Vinylpyridine (stabilised with TBC), 97.0%, 1g

Cerium(IV) oxide-nano powder 99.5+% APS 15-30 nm 50 g

L-Dihydroorotic acid, 98.0%, 10g